Ochratoxin A (ON is a toxin that contains an isocoumarin moiety linked by a peptide bond to phenylalanine. It is produced by certain Penicillium (mainly P. verrucosum) and Aspergillus (mainly A. ulutuceusl species of storage fungi. Total amounts of OA and other related toxins produced by these fungi are influenced by many factors. Several forms of OA have been discovered, some of which are highly toxic, whereas others have lower toxicity. Ochratoxin A has been detected in foods, feeds, animal tissues, and human blood in both Europe and North America. It has been implicated in the fatal human disease Balkan endemic nephropathy, has been shown to be a powerful carcinogen in rodents, and produces many other adverse effects in animals. It is absorbed passively throughout the gastrointestinal tract and in an active manner in the kidney. It is subjected to intestinal secretion and reabsorption via enterohepatic recycling. Binding of OA in the blood to the albumin fraction and recycling in the bile and kidney contributes to its long half-life in animals. Ochratoxin A is hydrolyzed to its nontoxic alpha form ( 0 1 x 1 by microorganisms in the rumen, cecum, and large intestine. The toxin is excreted primarily in the urine as Oa and to a lesser degree as OA; smaller amounts of OA and O a are generally excreted in the feces. Three distinct mechanisms of OA toxicity have been proposed; other toxic effects of OA seem to be secondary in nature. Several different strategies can be employed for controlling or neutralizing the effect of OA, including the use of proper storage conditions, the use of specific adsorbents to reduce absorption of OA, and the feeding OA-contaminated feedstuffs to ruminants. Antioxidants such as ascorbic acid have been shown to reduce the toxic effects of OA in laying hens. In summary, OA contamination of cereal food and feed may occur, given appropriate conditions. Implementation of suitable procedures may eliminate or minimize this potentially serious problem.
Introduction
Ochratoxin is a toxic compound that is commonly produced by two species of fungi, Penicillium verrucoswn Dierckx (Frisvad and Samson, 1991) and Aspergillus ochruceus Wilhelm (De Scott, 1985;  Frisvad and Samson, 1991) . The latter fungal species is now referred to as A. ulutaceus Berkeley 'Presented at a symposium titled: "Current Perspectives on
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Received January 21, 1992. Accepted July 28, 1992. et Curtis (Kozakiewicz, 1989) . The primary toxin was identified as ochratoxin A (OA); its less toxic dechloro analog is ochratoxin B (OB) (van der Merwe et al., 1965a,b) . Several other forms of ochratoxin also occur. Ochratoxin in recent years has received considerable attention because not only can it seriously affect animal performance and well-being, but it may also have deleterious effects on humans. Of greatest concern in humans is its implicated role in an irreversible and fatal kidney disease referred to as Balkan endemic nephropathy and its potent carcinogenic effects. This review discusses current information on the production of OA by certain species of fungi; naturally occurring ochratoxicosis; ochratoxicosis in pigs, poultry, ruminants, and laboratory animals; the acute and chronic effects of the toxin;
A REVIEW OF factors affecting absorption, distribution, biotransformations, and excretic,? of OA and its metabolites; its biochemical mechanism of action; the degree to which humans are exposed to the toxin; and means by which the toxic effects of OA can be reduced. Several reviews have been published on different aspects of OA (Chu, 1974; Cole and Cox, 1981; Roschenthaler et al., 1984; Steyn, 1984; Schaeffer and Hamilton, 1986;  Burns and Dwivedi, 1988 ; Dwivedi and Burns, 1988; Kuiper-Goodman, 1990 ; Marquardt et al., 1990; Pestka and Bondy, 19901 .
Chemistry of Ochrat oxins and General Toxicity
Ochratoxin A contains 7-carboxy-5-chloro-8-hydroxy9,4-dihydro-3R-methylisocoumarin (Oal that is linked through the 7-carboxy group to L-pphenylalanine by an amide bond. Several forms of ochratoxin occur (Table 1, Figure 11 , each of varying toxicity. In addition to OA, OB also exists in both the methyl and ethyl ester forms (Chu, 1974) . Hydroxylated forms of OA have been identified, including (4RI-OH-OA, (4S)-OH-OA, and 10-OH-OA Wormer et al., 19831 . Several analogs of OA have been prepared by substitution of phenylalanine with other amino acids (Creppy et al., 1983a1 . The tyrosine, valine, serine, and alanine analogs are most toxic, the methionine, tryptophan, and glutamic acid analogs have intermediate toxic effects, and the glutamate and proline analogs have low toxicity. Recently, Hadidane et al. (19911 have reported that the serine, hydroxyproline, and lysine analogs also occur naturally. Studies by Creppy et al. (1990) have also demonstrated that OA can be hydroxylated by phenylalanine hydroxylase to form the tyrosine analog of OA. 
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Ochratoxin A has two ionizable groups, the carboxyl group from phenylalanine and the 8-hydroxyl group, both of which can exist in the ionized or non-ionized form under physiological conditions. The dissociation constant (pKa1 of the 8-hydroxyl group is influenced by the structure of the OA; the pKa values are 7.05 to 7.10 for OA and ochratoxin C (OCI, 8.0 for OB, and 11 .O for Oa. Chu (1 9741 demonstrated that the 8-hydroxyl group must exist in the dissociated form for ochratoxin intoxication. The role of the carboxyl group in OA toxicity has not been reported. The chemical and physical properties have been reviewed in greater detail by Chu (19741, Cole and Cox (19811, and Steyn (19841. 
Ochrat oxin-Pro du cing Molds
The most important filamentous fungal genera invading cereal grains in storage are a large number of Penicillium and Aspergillus, several of which produce OA (Frisvad and Samson, 1991) . These fungi have been referred to as storage fungi. Among the Aspergillus species, A. alutaceus (A. ochraceus), A. ostianus, A. quercins (A. melleusl, and A. sulphureus (A. fresenii) produce OA. A. ochraceus is the only important cereal-borne producer of this toxin (Frisvad and Samson, 19911. Among the Pennicillium species, P. verrucosurn is the only known and confirmed producer of OA (Pitt, 1987 (Pitt, , 1988  Frisvad and Filtenborg, 1989;  Frisvad and Samson, 1991) . Two different strains of P. verrucosum have been identified, P. verrucosum chemotype I, which produces OA, verrucolon, and citrinin, and P. verrucosum chemotype 11, which produces only OA and verrucolon. Cereal-borne P. verrucosum (chemotype I11 has only been found in Denmark, Sweden, Norway, United Kingdom, Canada, and the United States (Frisvad and Filtenborg, 1989; Frisvad and Samson, 1991) . The reported production of OA by numerous other species of Penicillium and Aspergillus has been attributed to the difficulty associated with the correct identification of fungal species (Frisvad, 1989;  Pitt and Samson, 1990;  Samson and Frisvad, 1991) . These problems have been overcome by the introduction of new taxonomical techniques (Pitt and Samson, 19901. 
Factors That Influence Ochratoxin A Production
The amount of OA produced by any given species is influenced by many factors, including water activity (awl, temperature, type of substrate, presence of competitive microflora, strain of fungi, and integrity of the seed. The minimum a, values 3970 MARQUARDT AND FROHLICH &The location of the R groups on the ochratoxin molecule are outlined in Figure 1 . R 1 through 5 refers to that group bound to carbons 9, 5, 4, 4, and the number 3 methyl carbon, respectively, of ochratoxin.
for OA production by A. altutaceus and P. verrucosum were in the range of from .83 to .90. At 24"C, the optimum a, values were from .95 to .99 (Northolt et al., 1979) . At optimum h, the temperature range for OA production by A. alutaceus was 12 to W'C, whereas that for P. verrucosum was 4 to 31OC. These data correspond with observations on OA contamination in stored grain. The more psycophilic Penicillia, specifically P. verrucosum, is the major OA producer in cereals in the colder climatic zones, such as Scandinavia and Canada (Krogh, 1987) . In contrast, OA production in crops in the warmer climatic zones, such as Yugoslavia and Australia, is primarily by strains of A. alutaceus (Krogh, 1987) . The substrate on which Penicillium and Aspergillus species of fungi are grown greatly influences OA production (Filtenborg et al., 1990; Pitt and Samson, 1990 ). An in vitro study (Madhyastha et al., 1990) followed the time course production of OA, OB, and citrinin by two species of fungi, A. alutaceus and P. verrucosum, when grown on two grain crops (wheat and corn) and three oilseed crops (soybeans, peanuts, and rapeseed). The results as shown in Table 2 demonstrated that the oilseeds (peanuts and soybeans) supported a much higher production of OA and OB by A. alutaceus than did the grain crops (wheat and corn), whereas the two grains were a much better substrate for the production of OA and citrinin by P. verrucosum than the oilseed crops. Interestingly, OB was only produced by A. alutaceus when grown on the oilseed crops but not on the cereal crops. Also, there did not seem to be a close association between total amount of fungal mass and amount of mycotoxin produced.
The presence of competing microflora on a cereal substrate also affects the production of OA by A. alutaceus (Chelack et al., 1991al . These authors demonstrated that the production of OA by A. alutaceus on sterilized barley was much greater than its production of OA on unsterilized barley and that OA production by this fungus was greatly suppressed by the reintroduction of non OA-producing flora that had been isolated from the barley. It should therefore be possible to reduce the production of OA by A. alutaceus, and possibly that by P. verrucosum, by innoculation of high-moisture grain with a strain of bacteria or Oilseeds *Data from Madhyastha et al. (1990) .
Penicillium verrucosum Grains
bOB, dechloro form, low toxicity. CFungal mass as determined from glucosamine concentradLow because of low amount of fungal mass.
tion.
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fungi that does not produce the toxin. Conversely, if high OA production is required, it is important to ensure that the substrate does not contain competing flora. Finally, the strain of fungi also affects OA production. Roschenthaler et al. (1984) reported that even a well-known producer strain like A, ochraceus, NRRL 3174 (A. alutaceus), when subdivided and subcultured, yields variable amounts of OA. In a recent study, four variants of A. alutaceus were derived from this fungus after gamma irradiation (Chelack et al., 1991bl . The colony types obtained from barley that had been inoculated with the fungus and then irradiated were red (contains a water-soluble red pigment), ochre (parental), yellow, and white variants. The corresponding relative amounts of OA production, which varied by a factor of 100, were .09:1:4.8:9.3. The variants also had morphological and physiological characteristics different from those of the parent. The high-producing OA variants reverted spontaneously to the wild type, particularly under certain environmental conditions and in the presence of small amounts of the wild form of the fungus. Frohlich et al., 1991) demonstrated that the incidence of OA in the serum of market pigs was highest in July and that the highest serum concentrations occurred in October ( Holmberg et al. (1991) carried out a mycological analysis of feed samples obtained from OA-positive 12 2 ng/mL blood) and OA-negative herds ( < 2 ng/mL blood). No quantitative differences in mold content, as detected by colony forming units, were observed in the two groups. There were, however, differences in the mycoflora. The incidence of storage fungi (Penicillium and Aspergillus spp.1 was higher for positive herds, particularly the 3972 MARQUARDT AND FROHLICH Krogh, 19761, blood , and other tissues of pigs (Mortensen et al., 198313) . The concentration of OA is considerably higher in blood than in other tissues. Similar relationships for OA concentration in different tissues from the pig were obtained by Signatovich et al. (1 989) . Collectively, these data indicate that blood concentrations of OA of a few pigs could be used as a n index for predicting OA intake by the entire herd and to predict tissue concentrations. Thus, routine sampling of pig blood could be carried out in potentially problematic herds and a n appropriate feeding regimen could be introduced in contaminated herds to ensure clearance of OA from body tissues. The use of immunobased assays would greatly facilitate OA detection on the farm, in processing plants, and by regulatory agencies (Chu, 1992) .
Contamination of Food
Survey results in a number of European countries for residues of OA in kidneys from cases of porcine nephropathy have revealed that 25 to 29% of the cases contain OA in the range of 2 to 100 pg/kg (Krogh, 1987) . The practice in Denmark of monitoring kidney tissues of only those pigs that have detectable kidney lesions may not provide a good basis for condemnation of carcasses (Hald, 1991) because the intake of OA may not have been of sufficient duration to produce detectable lesions and yet it may be present in tissue, or the OA may be cleared from the body without regression of the lesion.
Ochratoxin A concentrations of up to 29 M/kg were found in the muscle of chickens collected at a slaughterhouse (Elling et al., 1975 Krogh, 19761. and muscle contained lower levels of OA, and no OA was found in eggs (Krogh, 1987) . Juszkiewicz et al. (1982) reported that no OA could be found in eggs of laying hens fed diets containing 2.5 mg/kg of OA, but that it was detected in the eggs of hens fed a high dosage of OA (10 mg/kgl.
Residues of OA are generally not found in ruminants because OA is cleaved in the rumen by protozoan and bacterial enzymes (Hult et al., 1976; Galtier and Alvinere, 1976; Patterson et al., 1981; Sreemannarayana et al., 1988; Xiao et al., 1991a,b) .
The nontoxic cleavage product, Oa, has been found in the blood in trace amounts and in the kidneys at levels < 10 pg/kg of calves experimentally fed diets containing OA (Patterson et al., 1981) . When two milking cows were experimentally fed a diet containing OA a t 317 to 1,125 pg/kg of feed for 11 wk, a residue of OA of 5 pg/kg was found in the kidney of one of the cows. No Oa was found in any tissue, and OA was not detected in any other tissue or in milk (Shreeve et al., 1979) . Sreemannarayana et al. (1988) followed the disposition of OA in preruminant calves. Approximately 90% of OA was excreted as Ocx, and approximately four to eight times more was found in the urine than in the feces. On average, < 2% of administered OA was secreted as OA in the urine and feces. A similar pattern was shown by Xiao et al. (1991a.b) .
Ochratoxicosis in Livestock and Laboratory Animals
Naturally Occurring Ochratoxicosis. Kidney diseases of unknown origin and subsequently attributed to the effect of OA were first identified in the Scandinavian countries in swine and in the Balkan countries in humans. The pioneering work of Elling and Moller (1973) with pigs demonstrated that OA was the major causal determinant of the disease that is now called mycotoxic porcine nephropathy (Krogh, 1987) . The renal lesions associated with disease include degeneration of the proximal tubules, interstitial fibrosis, and hyalinization of the glomeruli (Krogh et al., 1974; Krogh, 1978 Krogh, , 1987 . The disease is endemic in Denmark;
outbreaks are associated with a wet autumn and the storage of grain under high-moisture conditions. In Denmark, a positive association was observed between the prevalence rates of porcine nephropathy and frequency of OA contamination in corresponding feed samples (Krogh, 1987) . Cases of porcine nephropathy have also been observed in other European countries, including Sweden, Norway, Finland, Germany, Hungary, Poland, Yugoslavia, and Great Britain (Rutqvist et al., 1977 (Rutqvist et al., , 1978 Krogh, 1987; Jelinek et al., 1989) . The first documented field outbreak of ochratoxicosis in poultry resulted in a large increase in mortality in a house containing approximately 16,000 young turkeys. A total of 58% of the turkeys died by marketing age, and the survivors showed poor feed conversion, poor growth rates, and feed refusal. Histopathological examination revealed edematous, necrotic proximal tubes that seemed identical to those in turkeys fed OA (Hamilton et al., 1982) . A total of five independent episodes of ochratoxicosis in about 970,000 turkeys, two episodes in 70,000 laying hens, and two episodes in 12 million broiler chickens in the United States were investigated by Hamilton et al. (1982) . Toxin levels in the diet ranged from .3 to 18 mg/kg of diet. These infestations caused reductions in efficiency of feed utilization and increases in mortalities, the latter values ranging from 21 to 58%. These episodes were traced to contaminated corn (eight) or corn gluten meal (one). Naturally occurring cases of suspected mycotoxins, including OA, in the diet of laying birds have been reported from Hungary, the United States, Canada, Ukraine, Denmark, and Great Britain (Hamilton et al., 1982; Dwivedi and Burns, 1986; Schaeffer and Hamilton, 1986; Krogh, 1987; Kuiper-Goodman and Scott, 1989 ). These data demonstrate that OA toxicity can be a serious problem in the poultry industry.
Ochratoxicosis has rarely been reported in ruminants, presumably because of the ability of ruminal microorganisms to hydrolyze OA to the nontoxic alpha form (Sreemannarayana et al., 1988; Kuiper-Goodman and Scott, 1989; Xiao et al., 1991a,b) .
Acute Toxicity. Ochratoxin A is acutely toxic to several species of animals, including chicks, hens, ducklings, turkeys, rats, sheep, swine, and rainbow trout (Chu, 1974; Burns, 1984, 1988; Kuiper-Goodman and Scott, 1989; Marquardt et al., 19901 . The acute oral toxicities of OA when expressed as LD50 values (milligrams/kilogram BW) are 1.0 to 6.0 for pigs, 3.3 for chickens, .2 for dogs, 3.9 for neonatal rats, 20 to 30 for mature rats, and 46 to 58 for mice (Chu, 1974;  Krogh, 1987; Kuiper-Goodman and Scott, 1989) . No LD50 values have been reported for ruminants. Doses as high as 2.0 mg/kg BW, however, seemed to cause clinical depression, reduced BW, and dehydration in calves. By the end of 1 mo, however, the calves showed improvement in some of the clinical signs (Pier et al., 1976) . These results indicate that, in acute toxicity studies with OA, dogs and pigs are the most sensitive species and rats and mice, and possibly ruminants, are the least sensitive. As is the case with many xenobiotics, neonatal rats were considerably more susceptible than adult rats. Simultaneous oral administration of 100 mg/ kg BW of phenylalanine, which is a competitive inhibitor of OA, increased the oral LDso from 46 to 71 mg/kg BW (Moroi et al., 1985) .
The toxicities of different forms of ochratoxin are greatly different. The LDS0 values per young chick are as follows: OA, 150 pg (3 to 4 mg/kgl; OC, 216 pg; OB, 1,900 pg; and Oa, not toxic a t 1,000 pg (Chu, 19741 . This toxicity, as indicated earlier, is affected by the dissociation constant of the phenolic hydroxyl group. The OA and OC forms, which have similar molar toxicity values, have the same pKa values. Ochratoxin B is approximately 10 times less toxic than OA and also has a n acid dissociation constant that is 10 times smaller than that of OA. Ochratoxin alpha is nontoxic and does not dissociate under physiological conditions. It may be concluded that the acute toxicity of the ochratoxins, as assessed by the LDS0 values, varies considerably from species to species and within a species is influenced by diet, age, sex, route of administration, genetic differences and the form of ochratoxin.
The main clinical patterns associated with acute ochratoxicosis include initial anorexia, weight loss, emesis, and retching, followed by tenesmus, elevated rectal temperature, bilateral purulent conjunctivitis, tonsillitis, polydipsia, poly uria, passage of clots of blood-stained mucus from the rectum, dehydration, prostration, and death within 2 wk after administration of toxin. The symptoms manifest themselves earlier when a higher dose of OA is fed (Chu, 1974) . Birds dying of acute toxicosis show symptoms of listlessness, huddling, occasional diarrhea, ataxia, and prostration (Prior et al., 1978) .
Gross pathological examination of dogs administered .2 to 3.0 mg of OA/kg BW indicated moderate to severe mucohemmorrhagic enteritis of the cecum, colon, and rectum and enlargement of the lymph nodes, which were edematous, hyperemic, and focally necrotic. Histopathological examination indicates that renal damage is the main feature of this toxicosis (Szczech et al., 1973a,bl. In poultry there are reductions in serum levels of total protein, albumin, globulin, urea nitrogen, cholesterol, triglycerides, and potassium and in-creases in uric acid and creatine levels and in the activities of serum phosphatase, y-glutamyltransferase, and cholinesterase (Huff et al., 1988; Sreemannarayana et al., 1989) . Other biochemical signs of acute ochratoxicosis include decreases in sodium, potassium, and chlorine clearances (Puchlev, 1967 ) and large quantities of albumin and serum protein excretion in the urine (Bruckner et al., 1967) . Traits such as kidney weight and the serum concentrations of several proteins and metabolites and the activity of certain enzymes can be used as sensitive and earlier indicators of ochratoxicosis. Among these traits, Huff et al. (19881 concluded that serum total protein and albumin levels are the most sensitive indicators of ochratoxicosis in chickens. Other researchers have shown that a decrease in renal phosphoenolpyruvate carboxykinase (PEPCKI activity was a highly sensitive and specific indicator of OA toxicity in pigs, but not in rats (Krogh et al., 19881. Chronic Effects in Pigs. Pigs between 20 and 90 kg BW retained good health under specific-pathogenfree conditions but had reduced feed consumption, growth reduction, increased water consumption, and polyuria when the concentration of OA in the diet was increased from 0 to 2,300 pg/kg (Madsen et ai., 1982) . Levels ranging from 0 to 200 pg of OA/ kg of feed had little effect on daily gain and feed efficiency, whereas a significant influence was obtained when levels > 1,400 pg/kg were present in the feed. Even after several weeks of feeding OA, the performance of the pigs was normalized when the contaminated feed was replaced with normal feed. Krogh et al. (19741 reported that pigs fed diets containing 200 to 4,000 pg/kg of OA developed nephropathy after 4 mo at all levels of exposure.
All the lesions in the pigs were confined to the kidney, and most of the renal disturbances were associated with damage to the proximal tubules. Changes in tubular function were indicated by a decreased transport maximum of p-aminohippuric acid (Tm-PAH), a decreased Tm-PAH/inulin clearance, a n increased excretion of glucose, and a reduced ability to produce a concentrated urine. There was a dose-response-related increase in protein excretion in the urine consisting mainly of albumin and proteins with a similar or large molecular weight, indicating a "glomerular" proteinuria. Polydipsia and significant increases in the concentration of creatinine and urea in the blood occurred in the highest exposure group after 4 to 6 wk. These functional changes corresponded well with changes in renal structure observed at all exposure levels, including atrophy of the proximal tubules, and interstitial cortical fibrosis. Scleratinized glomeruli were also observed in the group that received 4,000 pg of OA/kg of feed. No other organ or tissue exhibited any change.
Pigs given high peroral doses, corresponding to feed levels of > 5 to 10 mg/kg, produced extrarenal effects involving the liver, intestine, spleen, lymphoid tissue, and leukocytes, in addition to renal lesions (Szczech et al., 1973~) . Increased urinary levels of lactate dehydrogenase, isocitrate dehydrogenase, and glutamic-oxaloacetic transaminase also occurred. The levels of OA fed in these experiments were much higher than those that occur naturally.
The activity of renal PEPCK and 'yglutamyltransferase decreased by 4 0% in pigs within 1 wk of their being fed 2,000 or 1,000 mg of OA/kg of diet (Krogh et al., 1988) . These decreases in enzyme activity were accompanied by a dose aggravation of renal impairment as measured by the reduction of Tm-PAH/inulin clearance, s u g gesting that these enzymes, and PEPCK in particular, are sensitive indicators of OA-induced porcine nephropathy. Thus, renal measurements of enzyme activities as indicated earlier might prove diagnostically useful measures of OA-induced kidney lesions. Other chronic conditions that could also affect the pig are reviewed below.
Chronic Effect in Poultry and Other Classes of
Livestock. The incorporation of OA into the diet of broiler chicks during a 3-wk period at concentrations of .5, 1.0, 2.0, 4.0, and 8.0 mg of OA/kg of diet reduced weight gains relative to those of the controls by approximately 0, 0, 24, 50, and 8O%, respectively (Huff et al., 1974) . Prior and Sisodia (1978) reported that there was a significant reduction in egg production and feed consumption when laying hens were fed a diet containing as little as .5 mg of OA/kg of diet over a 6-wk period. Huff et al. (19741, on the basis of growth inhibition and other effects, concluded that OA was the most potent mycotoxin yet studied in chickens.
The target organ of OA for poultry, as reported for other species, seems to be the kidney, although other systems such as the liver, gastrointestinal tract, lymphoid organs, skeletal system, hematopoietic tissues, and the reproductive organs can be affected (Burns and Dwivedi, 1986) . Specific effects of OA include reduced rate of growth (Dwivedi and Burns, 19861 , impaired coagulation of blood (Doerr et al., 19811 , decreased skeletal integrity (Huff et al., 19801, anemia (Huff et al., 1979a1, leucocytopenia (Chang et al., 19791, altered glycogenesis (Huff et al., 1979b Warren and Hamilton, 1980a1 , altered intestinal fragility (Warren and Hamilton, 198Ob1, nephropathy (Huff et al., 19751, impaired phagocytosis (Chang and Hamilton, 19801 , and altered concentrations of serum constituents as mentioned above in the discussion of acute toxicity (Huff et al., 1988; Sreemannarayana et al., 1989) . Further details on the chronic effects of OA in poultry are presented in the review by Burns and Dwivedi (1986) and Dwivedi and Burns (1986) and in the subsequent section.
Very little information is available on the chronic effects of OA in other classes of livestock including the ruminants (Krogh, 1987; KuiperGoodman and Scott, 1989) .
Teratology and Reproduction.
Ochratoxin A is a potent teratogen in mice, rats, hamsters, and chickens (Fukui et al., 19871, but not in pigs (Shreeve et al., 19771. Species differences in susceptibility to the teratogenic effects of OA have been attributed in part to differences in placental transfer of OA (Fukui et al., 19871 . The central nervous system, the eye, and the axial skeleton are mainly affected in the offspring of OA-treated females (Kuiper-Goodman and Scott, 1989) . Peroral administration of a single dosage of OA as low as 1.0 mg/kg BW during gestation produced gross malformations in the fetus of the mouse and the rat. Pigs from sows fed 700 or 1,400 pg of OA/kg of feed seemed to be clinically normal. Ochratoxin A was not detected in the newborn pigs or the sows (Mortensen et al., 1983a) .
Dietary OA presumably does not have a significant teratogenic effect on the chick because little or no OA can be detected in the eggs of hens fed up to 2.5 mg/kg of feed (Juszkiewicz et al., 1982) . However, OA, when injected into the air sac of the embryonated egg, produces malformations in the embryo at very low concentrations (Vesela et al., 1983) . Kuiper-Goodman and Scott (1989) have summarized the teratogenic and reproductive dose-response effects of OA in rodents.
Genotoxicity. Overall, OA is not a mutagen, but it is weakly genotoxic to mammalian cells. The genotoxicity of OA has been reviewed (Bendele et al., 1985; Kuiper-Goodman and Scott, 1989) .
Effect on Carbohydrate hfetabohrn. Ochratoxin A has an effect on glucose and insulin metabolism (Subramanian et al., 1989a,b) , promotes glycogen accumulation in liver (Pitout, 1968; Huff et al., 1979b) by inhibiting the activation of glycogenolysis via the CAMP-dependent protein kinase (Warren and Hamilton, 1980a1 , and inhibits the activity of a key gluconeogenic enzyme in the kidney, PEPCK (Meisner and Meisner, 1981; Meisner and Krogh, 1986; Krogh et al., 1988) . The concentration of OA required to inhibit 50Y0 of PEPCK in pigs is 4 w;/kg BW, whereas in rats, 1,000 to 2,000 pg/kg body weight is required.
Immunotoxicity. Studies with laboratory animals have indicated that OA causes immunomodulation (Hong et al., 1988) . The depletion of lymphoid cells after OA ingestion, particularly in the thymus, bursa of Fabricius, spleen, and Peers patches, has been reported for different species of animals Burns, 1984,1985 ; Szczech et al., 1Q73b, c) . Depletion of the thymus occurs concurrently with a delayed hypersensitivity response, suggesting a possible suppression of cellmediated immunity by OA (Dwivedi and Burns, 19851. Ochratoxin A when fed to chickens decreases phagocytosis and locomotion of heterophils and monocytes (Chang and Hamilton, 1980; Chang, 1982) and increases circulating heterophils (Campbell et al., 1983) . It also causes a dose-dependent reduction in bone marrow macrophage-granulocyte progenitors, a reduction of spleen and bone marrow hematopoietic pluripotent stem cells, and an increase in macrophage activation Boorman et al., 1984) . Luster et al. (19871 reported that OA induced decreases in natural killer cell activity by the specific inhibition of endogenous interferon levels. Because natural killer cells are involved in the destruction of tumor cells, the ability of OA to modulate the activity of these cells might contribute to its capacity to induce renal and hepatic carcinomas. More recently, Lea et al. (1989) reported that OA had a potent inhibitory effect both at the level of B and T lymphocytes. These observations confirm and extend the previous observations that OA has potent immunosuppressive properties. Oral doses of 2 to 4 mg/kg BW in the diet for 20 d decreased the lymphoid cell population in the chicken (Dwivedi and Burns, 18841 , whereas in the mouse, functional alterations in bone marrow cells and macrophages have been produced at doses that do not induce overt nephrotoxicity (Boorman et al., 1984) . Reviews of OA in the immune system have been published (Burns and Dwivedi, 1986; Kuiper-Goodman and Scott, 1989; Pestka and Bondy, 1990) .
Carcinogenicity. Bendele et al. (lQ85) reported a high incidence of renal adenomas and carcinomas (62O/0) in mice fed 34 mg of OA/kg of diet but not in those fed 1 mg/kg of OA. Boorman (1989) carried out an extensive carcinogenicity study using male and female Fisher 344/N rats. In this study OA was administered in corn by gavage at 0, 21, 70, and 210 pg/kg BW per day on 5 d/wk for 24 mo. The percentage of renal tubular adenomas plus carcinomas for male and female rats administered 0, 21, 70, or 210 w; of OA were 2 and 0; 2 and 0; 39 and 4; and 72 and 16, respectively. The incidence of renal tubular cell adenomas and carcinomas observed in the male rats was much higher than that in the female rats and for the male rats was the highest seen in any study of the National Cancer Institute or the National Toxicology Program to date. At the highest dose levels, many of the renal tumors were multiple or bilateral. The significance of the OA-induced rat renal carcinoma is increased by the frequency of metastases, particularly in the lungs and lymph nodes. In the female rats given the high dose, there was also an increased incidence in the multiplicity of fibroadenomas in the mammary gland compared with the controls. In-depth reviews on the carcinogenicity of OA have been published (Kuiper-Goodman and Scott, 1989; Huff, 19911. 
Pharmacokinetics of Ochratoxin A
Factors that affect the pharmacokinetic patterns of absorption, distribution, metabolism [hydrolysis and hydroxylation), and excretion of OA for several species of animals have been recently reviewed (Kuiper-Goodman and Scott, 1989; Marquardt et al., 19901 . Current evidence suggests that in most species of animals OA is absorbed primarily from the stomach (Galtier, 1978;  Kumagai and Aibara, 1982; Roth et al., 1988) . Lee et al. (1984) reported that OA absorption took place maximally in the esophagus and to a lesser degree in the jejunum. The failure to see absorption in the ileum was attributed to the low luminal concentration a t that point of the gastrointestinal tract rather than to the lack of uptake by the ileal mucosal membrane. Thus, the bioavailability of OA, which is the amount of OA reaching the systemic circulation, will affect the toxicity of OA.
Another factor that affects OA toxicity is the high binding affinity of OA to plasma constituents (Chu, 1971 Uchiyama and Saito, 1987) . This not only facilitates the passive absorption of the nonionized form of OA from the digestive system (Kumagai, 1988) but also retards OA elimination and consequently contributes to the prolonged half-life of the toxin (Kumagai, 1985; Hagelberg et al., 1989) . The role of albumin in the pharmacokinetics of OA was illustrated in the study of Kumagai (1985) with albumin-deficient rats. These rats, which had a n albumin concentration of approximately 1 YO of that found in the normal rat, were able to clear OA from the systemic circulation 20-to 70-fold faster than normal rats. It was concluded that one of the primary effects of albumin binding on OA is to retard its elimination, by limiting the transfer of OA from the bloodstream to the hepatic and renal cells. Stojkovic et al. (1984) presented evidence that suggested that there is a smaller molecular weight fraction in blood (Le., 20,000 Da) that binds OA more specifically than plasma albumins. They concluded that the binding of OA to these proteins may be relevant to its predominant nephrotoxic effect in mammals because such molecules can easily pass through the normal glomular membrane, enabling the accumulation of OA into the kidney. This same process cannot occur when OA is bound to albumin. The association constants for the high-affinity macromolecules in human and porcine plasma were found to be 2.3 x 1O1O M-I and .6 x 1Olo M-I, respectively. Uchiyama and Saito (19871 demonstrated that OA had little affinity for the soluble tissue proteins of liver and kidney and that the al-, a2-, p-, and y-globulins had a much lower affinity for OA than human serum albumin. The association constant of OA for human serum albumin was 6 x lo5 M-I, with 2.2 mol of OA being bound per mole of albumin. The relationship between the toxicokinetics of OA in several s p e cies and its plasma-binding properties was further investigated by Hagelberg et al. (19891. These authors reported that plasma of several species of animals have proteins with different binding affinities for OA. The association constant for the highaffinity proteins were 5 x lo5, 40 x lo5, .7 x lo5, 2 x lo5, and 1 x lo5 M-l for the quail, rat, monkey, pig, and human, respectively. These values are considerably different from those reported by Stojkovic et al. (19841 but similar to those reported by Uchiyama and Saito (1 9871. The corresponding percentage of toxin that was in the free or unbound form was very low: .2, .02, .08., .1, and .02, respectively. These results show that the fraction of free toxin varied considerably; it was 10 times greater in the quail than in the rat and human and more than twice that in the monkey. The elimination half-lives after intravenous injection of OA were 12 h for the quail, 170 h for the rat, 150 h for the pig, and an astonishing 840 h for the monkey. These values suggest that there is a positive association between the binding of OA to plasma protein and the elimination half-life. Hagelberg et al. (19891, however, concluded that the precise relationship among strong-protein binding of OA, a low rate of clearance of OA from the systemic circulation, and OA toxicity is unknown.
Ochratoxin A seems to be absorbed in a passive manner from the gastrointestinal tract in the nonionized or partially ionized form rather than in the ionized form (Kumagai, 1988) . The hydroxyl group of OA, which seems to be of primary importance in the absorption of OA, exists in the nonionized form at a low pH and in the ionized form a t a high pH. The proportion of the two forms can be calculated from its pKa value (7.11. The influence that the second ionizable group, the carboxy group, has on the absorption of OA has not been reported. It may have an effect because its pKa value would presumably be considerably lower than that of the hydroxyl group (Metzler, 19771 . The pH of digesta should therefore affect the rate of absorption of OA, the rate being faster in those sections of the gastrointestinal tract that have a low rather than a high pH. Presumably the low pH of the rumen, particularly in animals fed diets high in grain and low in hay, would facilitate direct uptake of OA into the blood from the rumen Niao, 1991a,b). Sreemannarayana et al. (1988) reported that OA absorption in ruminal calves after they received OA orally occurred in two stages. Ochratoxin A was absorbed by a first-order process (ka=.5/h) starting immediately after dosing, followed by a rapid mono-exponential decline (hz = .25/h), the latter corresponding to the distribution phase. After some considerable delay (tlag = 12.8 h), absorption seemed to resume again by another, but slower, first-order process (k'a = .12/h), leading to a broad peak in the OA concentration time curve. The terminal segment declined mono-ex ponentially (Xz = .037/hl. The slowness of the terminal kinetics is consistent with a prolonged biological half-life for OA. The results suggested that OA was rapidly absorbed from the rumen (approximately 50%/h). The pronounced secondary peak in the serum OA concentration-profile strongly suggests that this was attributable to enterohepatic recycling of OA. The single protracted secondary peak suggests that biliary recycling of OA is a continuous process superimposed on the overall process of elimination. Reabsorption of OA from the intestine back into the circulation, which is a consequence of biliary recycling, favors the systemic redistribution of OA among the different tissue sites. This leads to overexposure of susceptible target organs, such as the kidney and liver, and contributes to the deleterious action of OA as a toxin. Roth et al. (1988) and Fuchs et al. (19881 also reported secondary distribution peaks of OA in the intestinal content and serum of rodents, which was considered to be a consequence of enterohepatic circulation. Roth et al. (1988) also reported that a considerable portion of OA was secreted in the bile in a conjugated form (glucuronides and sulfates) and that the conjugates probably were hydrolyzed to OA or Oa by the intestinal microflora before reabsorption.
An efficient reabsorption of OA by the renal tubules of the kidney also facilitates reabsorption of OA into the plasma, which is also an important factor in facilitating the residual persistence of the mycotoxin in the kidney and probably in the body (Stein et al., 1985) . This recycling occurs in the renal proximal tubules and may be responsible for gross changes in the kidney, including progressive degeneration of renal tubules in rats (Albassam et al., 19871, pigs (Szczech et al., 1973~1 , and chicken (Elling et al., 1975; Elling, 1979) . Jung and Endou (1989) have shown that only the middle and the terminal portion of the nephrons seem to be affected by OA. They demonstrated that OA very efficiently inhibited ATP synthesis in mitochondria from these segments of the kidney, but not from several other segments. Protection by probenecid demonstrated that OA entered the plasma membrane in the nephron through the anion transport pathway (Stein et al., 1985; Jung and Endou, 1989) . This mechanism of absorption in the kidney seems to be different from that for absorption from the gastrointestinal tract.
The influence of the intestinal microorganisms on the disposition of OA in the nonruminant animal, particularly those in the cecum and large intestine, has received limited attention. Madhyastha et al. (1992b) reported that microorganisms in digesta from the cecum and large intestine of the rat were capable of hydrolysing OA in vitro.
Acid hydrolysis of OA in the stomach and enzymatic hydrolysis in the small intestine by pancreatic enzymes seem to be quantitatively unimportant . Clearance studies with OA demonstrated that the presence of a broad-spectrum antibiotic, neomycin, in the diet greatly increased the amount of OA excreted in the feces and decreased total excretion of O a in the urine (Madhyastha et al., 1992b) . These results indicate that the microbial populations in the nonruminant animal affect the disposition of OA, presumably by affecting the degree to which OA is hydrolyzed. Although OA is efficiently hydrolyzed by enzymes produced by the intestinal microorganisms it is not hydrolyzed in vitro by kidney and liver homogenates (Kanisawa et al., 1977; Suzuki et al., 1977; Stormer et al., 1983; Madhyastha et al., 1992b) . The failure to detect any O a in the urine or feces of the preruminant calf after intravenous administration of OA also supports data that OA is not hydrolyzed in vivo by animal tissues (Sreemannarayana et al., 1988) .
In addition to being converted to Oa, a small percentage of absorbed OA is converted to hydrox yochratoxin A, Stormer and Pederson (1980) demonstrated that liver microsomes from humans, pigs, and rats are capable of metabolizing OA in the presence of NADPH to (4R)-and (4SI-hydroxyochratoxin A. These observations suggested that microsomal hydroxylation occurs in the cytochrome P-450 system (Stormer and Pederson, 1980) . In vivo studies demonstrated that 1 to 1.5% of orally administered OA was excreted in the urine as (4R)-hydroxyochratoxin A and 25 to 27% as Ool (Storen et al., 1982) . Stormer et al. (1983) reported that rabbit liver microsomes in addition to producing the 4R and 4 s isomers also produced 10-hydroxyochratoxin A. Metabolism of OA to the hydroxylated form increased in phenobarbitaltreated mice and, as a result, its toxicity decreased (Stormer et al., 1983) . Hutchinson et al. (1971) reported that the 4-hydroxy forms of OA were nontoxic when administered to rats, whereas Creppy et al. (1983a Creppy et al. ( ,b, 1980 reported that OA and the 4R-hydroxy form of OA were equally toxic to yeast and that both inhibited phenylalanyl-tRNA synthetase to a similar degree. The lower toxicity of the hydroxy form of OA to mammals may possibly be attributed to a faster rate of clearance in the urine or feces compared with that of OA. Recent results by Castegnaro et al. (1989) demonstrated a difference between two strains of rats in their ability to form 4-hydroxy-OA and that this difference was associated with a difference between the strains in a genetic polymorphism for debrisoquine 4-hydroxylation. The relationship between degree of hydroxylation of OA and the susceptibility of rats to the nephrotoxic effects of OA was not established. Castegnaro et al. (19891, nevertheless, hypothesized that there is a positive association between the ability of animals to hydroxylate OA and the incidence of OA-induced tumor induction. Recently another form of OA, tyrosine-OA, was found in the liver of OA-poisoned animals (Creppy et al., 1990) . The synthetic form of this compound was shown to have a similar toxicity to OA in hepatoma tissue culture cells (Creppy et al., 1983a ,bl and in chicken embryo assays W e i and Chu, 1974) . It was postulated that this compound could be metabolized further to give rise to (4R)-or (4S)-hydroxytyrosine OA or other metabolites (Creppy et al., 1990) .
Overall, OA is absorbed in the upper portions of the gastrointestinal tract in a passive manner in the nonionized form and is subjected to secretion and reabsorption via enterohepatic recycling. The rate and site of absorption of OA in the gastrointestinal tract is probably influenced by the pH of the intestinal contents because absorption occurs best when OA is not ionized. This occurs at low pH values but not a t neutral pH values. Ochratoxin A is also reabsorbed in a n active manner via the organic anion transport system in the proximal and distal tubules of the kidney. Binding of OA in the blood to the albumin fraction and recycling in the bile and kidney contributes to its long half-life in animaIs. Hydrolysis of OA by microorganisms in the rumen, cecum, and large intestine facilitates the excretion of OA in the nontoxic alpha form. Ochratoxin A is also hydroxylated by the microsomal fraction within the liver. This form of OA may be more readily eliminated from the body but may also be more carcinogenic. The toxin is primarily excreted in the urine as Oa and to a lesser degree as OA; much smaller amounts of OA and O a generally are excreted in the feces. A schema for the disposition of OA is given in Figure   2 .
Mechanisms of Ochratoxicosis
It would seem that there may be more than one direct effect and several indirect effects of OA. The primary effects seem to be associated with a n effect of OA on the enzymes involved in phenylalanine metabolism, including phenylalanyl transferase and phenylalanine hydroxylase, a n effect on lipid peroxidation, and a n effect on mitochondrial function.
Ochratoxin A affects DNA, RNA, and protein synthesis in many different organisms (Meisner and Meisner, 1981; Creppy et al., 1983a Creppy et al., ,b, 1980 Meisner et al., 1983; Roschenthaler et al., 1984; Meisner and Krogh, 1986; Meisner and Polsinelli, 19801 , presumably due to a n effect by the phenylalanine moiety of the molecule. Protein (Meisner and Meisner, 1981) and mRNA pools (Meisner et al., 1983) are reduced in kidney cells by 30 to 40%, whereas renal gluconeogenesis and cytosolic PEPCK activity can be almost completely inhibited in rats (Meisner and Meisner, 1981) and swine (Meisner and Krogh, 1980; Krogh, 1987) by OA. The enzyme PEPCK is a key regulator of the gluconeogenic pathway and is transcriptionally regulated in the kidney by various hormonal and dietary treatments (Meisner et al., 1985) . Creppy et al. (19861 studied the effect of OA on macromolecule synthesis in vitro in kidney cells in the presence and absence of phenylalanine, a structural component of OA. The synthesis of RNA and DNA and the enzymatic activity of five enzymes were inhibited by OA in a dose-dependent manner after 24 h of incubation. The toxicity of OA was prevented by the addition of phenylalanine to the incubation mixture, suggesting that the phenylala nine moiety of OA was involved in the toxic action of OA. The effects of OA on macromolecule synthesis in prokaryotic and eukaryotic microorganisms and animal hormones have been reviewed .
The mode of action of OA a t the molecular level has been further investigated by Meisner and Polsinelli (1986) . Nuclear runoff experiments demonstrated that the rate of transcription of the gene coding for OA-sensitive RNA, including that for PEPCK, was not affected by OA. They also reported that translational efficiency of PEPCK mRNA was unchanged in OA-treated rats. They concluded that the toxin must therefore affect the concentration of certain mRNA by a posttranscriptional mechanisms. At the posttranscriptional level, the effect of OA may be in the RNA processing (poly-A addition, splicing, or capping), translational efficiency, or degradation rate. Although none of these can be ruled out, they suggested that in view of the known effects of hormones, and so on, on RNA turnover (Brock and Shapiro, 19831 , it is most likely that OA perturbs this process. Nevertheless, it seems that neither the rate of mRNA synthesis nor the rate of degradation is affected by OA. Further research is required to explain the mechanism by which OA affects the turnover of macromolecules. Perhaps the effect of OA on protein, RNA, and DNA synthesis is a result of some other primary mechanism.
Ochratoxin A also inhibits phenylalanine hydroxylase (Creppy et al., 19841 . The degree of inhibition of this enzyme in the presence of phenylalanine was found to be in the same range as that obtained with other halogenated analogs (Dhondt et al., 1980) . Ochratoxin alpha, in contrast, was not effective, which indicates that the isocoumarin portion of the molecule was not necessary for the inhibitory effect of OA. This suggests that a competition between OA and phenylalanine for phenylalanine hydroxylase is likely involved. Creppy et al. (1984 Creppy et al. ( , 1990 suggested that small amounts of OA in the diet should reduce the activity of phenylalanine hydroxylase and therefore reduce the rate of flux of phenylalanine through tyrosine and related metabolites. In addition, this blockage of phenylalanine hydroxylase activity could produce "phenylketonuria-like" effects, including an enhanced production of phenylpyruvate and phenylacetate. The failure of OA to deplete ATP in rat hepatocytes would suggest that the mitochondrial mechanism, as discussed subsequently, probably did not contribute to the effects observed by Creppy et al. (19901. A second mechanism of OA toxicity has been proposed by Rahimtula et al. (19881. They demon strated that OA enhanced lipid peroxidation when added to liver or kidney microsomes or when administered to rats in vivo. In vitro, OA stimulated both NADPH-dependent microsomal and ascorbate-dependent lipid peroxidation, with iron being a n essential co-factor. Ochratoxin A stimulated lipid peroxidation by complexing with iron, facilitating the reduction of iron . Hasinoff et al. (19901 reported that the ironcomplex of OA produced the extremely toxic hydroxyl radical in the presence of the NADPHcytochrome P-450 reductase system. They s u g gested that this radical species may be partly responsible for OA toxicity. Administration of OA to rats also stimulated the exhalation of large amounts of ethane (Rahimtula et al., 19881 , an in vivo measure of lipid peroxidation (Kappus, 1985) . Ale0 et al. (19911 also reported that OA stimulated lipid peroxidation in isolated rat renal proximal tubules. Khan et al. (1989) have shown that OAenhanced lipid peroxidation was also accompanied by leakage of calcium from calciumloaded microsomes. Various agents that were able to inhibit OA-enhanced lipid peroxidation were also able to block the destruction of calcium uptake activity. Lipid peroxidation may be an early event in hepatotoxicity, which results in structural changes in the cell membrane sufficient to allow a n influx of cellular calcium to cause changes in metabolic activity within the cell and ultimately cause cell necrosis (Orrenius and Bellomo, 1986) . The extent of OA-dependent lipid peroxidation in vivo and its role in the toxicity of OA remain to be determined.
A third mechanism of OA toxicity is its effect on mitochondrial ATP production. During in vitro studies of the rat liver mitochondria it was observed that OA inhibited the respiration of whole mitochondria by acting as a competitive inhibitor of carrier proteins located in the inner mitochondrial membrane (Meisner and Chan, 1974; Wei et al., 19851 . Other studies with mitochondrial preparations revealed that the mitochondrial uptake of OA was a n energyconsuming process that resulted in the depletion of intramitochondrial ATP and that OA inhibited intramitochondrial phosphate transport, resulting in deterioration of the mitochondria Meisner, 19761 . Ochratoxin A has also been shown to alter mitochondrial morphology after in vivo administration (Suzuki et al., 1975) . Ale0 et al. (19911 have recently presented data suggesting that OA toxicity in the proximal tubules of the rat was primarily related to inhibition of mitochondrial function and was not related to iron-mediated lipid peroxidation as measured by malondialdehyde production. In these studies the toxic effects of OA on the mitochondria, as measured by increased lactate dehydrogenase release and decreased ATP production, was not ameliorated when a n iron chelator, desferoxamine, was used to selectively inhibit the production of lipid peroxides. These studies, however, did not conclusively rule out the importance of lipid peroxidation (Rahimtula et al., 1988) or perturbed calcium homeostasis Khan et al., 1989) in the development of OA-induced hepatotoxicity or nephrotoxicity. The importance of the mitochondrial mechanism is not clear because Oa, which is nontoxic, was also able to inhibit mitochrondrial state-three respiration more effectively than was OA (Moore and Truelove, 1970) .
Human Exposure to Ochratoxins
In a study in Yugoslavia, in a n area where endemic nephropathy is prevalent, 639 sera from the inhabitants of two villages were screened for the presence of OA, and 6.6% were positive for the toxin. The concentration ranged from 2 to 57 ng/g (Hult et al., 19821. In addition, about one-third of patients dying from Balkan endemic nephropathy (BEN) had papillomas and(or1 carcinomas of the renal pelvis, ureter, or bladder (Castegnaro and Chernozemsky, 1987) . In one endemic area in Bulgaria, the relative risk of patients with BEN developing urinary tract tumors was 90-fold higher than in the populations from non-endemic areas (Castegnaro and Chernozemsky, 1987) . Studies in Yugoslavia are particularly relevant because the presence of OA in food has been speculatively associated with human endemic nephropathy in this and other Balkan countries (Hult et al., 1982; Krogh, 1987) .
In West Germany, 57% of 306 samples of human serum tested positive for OA; the concentration ranged from .1 to 14.4 ng/g. Approximately 10% of human milk samples had traces of OA (Bauer and Gareis, 1987; Gareis et al., 1988) . Recently, Breitholtz et al. (1991) reported that the average concentration of OA in plasma in three areas of Sweden were .02, .03, and .26 ng/mL for the Uppsala, Ostersund, and Visby regions. They attributed the striking difference in the occurrence and level of OA between the district of Visby and the other two districts to a high exposure of local products such as cereal-based foods, as well as pig and poultry meat. The presence of OA in human blood is not unexpected because OA has been shown to occur in grain harvested in these countries and such grain has been associated with nephropathy in swine (Krogh, 1978; Holmberg et al., 1991) . Ochratoxin A has also been detected in 40% of human blood samples (n = 159) in Canada (Frohlich et al., 1991) . The percentage of the population falling into concentration groups > .3, .7, 2.2, and 35 ng of OA/mL of blood was 28, 6, 5 , and 1%, respectively. The presence of OA in human blood in Canada is also not unexpected in view of the high potential to produce OA in moisturized grain (Frohlich et al., 1991) and the extent to which OA has been detected in swine blood (Marquardt et al., 1988) .
The significance of the presence of OA in human blood has been addressed in part by the risk assessment reports by Kuiper-Goodman and Scott (19891 and Kuiper-Goodman (19901. KuiperGoodman (1990) estimated overall tolerable daily intake for OA, based on epidemiological data, to be about .2 to 4.2 ng/kg BW per day for a risk of 1 per 106 persons. Comparative values for aflatoxin (B form) is .014 and for zearalenone 50 to 100 ng/kg BW per day. The safety factor for OA reflects interspecies and intraspecies differences, the biological significance of the tumors induced, and the concern that even a t very low doses initiation of the carcinogenic process may take place. The estimated tolerable daily intake for Canada may be adjusted downward depending on the weight of evidence from biological factors that become known. Strong binding of OA to human serum, a long serum half-life of OA in the rhesus monkey (510 h, Hagelberg et al., 1989) compared with that in the rat (55 to 120 h, Galtier et al., 1979; Hagelberg et al., 19891 , and an astonishing persistence of the toxin in human blood (Hagelberg et al., 1989) suggest that OA may be considerably more toxic to humans than to rats. Kuiper-Goodman (1990) estimated that the average intake of OA in Canada was about 5 ng/kg BW per day, the major portion being derived from cereal food products. This is slightly more than the tolerable daily intake. Corresponding estimated intakes in Canada of aflatoxins as aflatoxin B1 or its equivalent and of zearalenone may reach 12.5 and 50 to 100 ng/kg BW per day, respectively. Intake of aflatoxin is much higher than the estimated tolerable intake, whereas that of zearalenone is approximately equal to the tolerable intake. The calculated daily intake of OA in individuals with high plasma OA concentrations would suggest that there is need for concern about OA intake in certain individuals in Sweden and Canada. Kuiper-Goodman and Scott (19891 concluded that further monitoring programs are required to define more precisely the overall residue profile in cereal grains, animal feeds, animal food products, and human blood. Such data will provide a basis for establishing dietary exposure and for ascertaining the need for regulatory or other control mechanisms.
In contrast to the tolerable daily intake of .2 to 4.2 ng of OMkg BW recommended by KuiperGoodman and Scott (19891, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) suggested that the tolerable weekly intake of OA should be 112 ng/kg BW. This value, which is equal to 16 ng/kg BW per day, is considerably higher than that recommended by the researchers mentioned previously. The recommendation by JECFA is based on a 500-fold margin of safety applied to the lowest-observed-effect level (LOEL), .008 mg/kg BW per day (Herrman, 1991) . This committee delayed making recommendations after establishing Codex quicklines until more information was available on the occurrence of OA in various food commodities.
Although OA concentrations have not been regulated in the United States or Canada, at least 11 countries have or have proposed regulations for OA (Jelinek et al., 1989; Van Egmond, 1991) . In Europe, OA is the toxin of greatest concern, particularly in West Germany (Fink-Gremmels, 1991) . The maximum tolerated concentration for OA in food, animal feed, and animal organs, however, varies greatly from country to country. This ranges from a high of 1,000 pg/kg for a complete poultry feed in Sweden to a low of 3 pg/ kg (proposed) in the Netherlands and is generally e 20 pg/kg for human foods. The rationale for setting limits in each country has not been published. On the basis of limited surveys, Wood (1992) concluded that OA residues in human food products was not high enough to be of concern in the United States.
Reducing Ochratoxin-Associated Risks
Several different strategies can be employed to reduce human exposure to OA or to reduce its toxic effects when it is fed to animals. These include the use of management practices to prevent the production of OA by the storage fungi, the feeding of contaminated grain to animal species that are less susceptible to the toxic effects of OA, such as ruminants, modification of the diet to promote enhanced hydrolysis of OA in the gastrointestinal tract or reduced absorption, and the use of a feeding regimen that can counteract the metabolic effects of OA.
Prevention of Growth of Storage Fungi. Conditions favoring the development of mycotoxins in cereals before and after harvest are not well understood. Some of the factors likely to affect mycotoxin formation are moisture, temperature, time, d a m age to the seed, 0 2 and C02 concentrations, composition of substrate, fungal abundance, prevalence of toxigenic strains, spore loads, microbiological interactions, and invertebrate vectors . The most important factors in safeguarding stored foodstuffs from OA production by molds are its moisture content (water activity) and temperature (Northolt et al., 1979) . Large quantities of OA can be produced at intermediate and high ambient temperatures and high moisture contents by species belonging to the Penicillium and Aspergillus, whereas at lower ambient temperatures the toxin can be produced by penicillia only. Abramson et al. (19901 demonstrated that very little OA was produced in wheat stored for 80 wk a t 16% moisture, but a t 19% moisture OA was detected. Corn when stored for 52 wk at 21% moisture produced 3.6 ppm OA, whereas none of this toxin was found in corn stored a t 16% moisture . These results indicate that fungi on cereal grains stored at moisture contents c 15% generally do not produce OA. The production of OA in barley when stored in high-moisture silos has been reported (Frohlich et al., 1991) . This may be attributed to the leakage of air into the silo, which would then provide a n environment favorable for the production of OA by indigenous OA-producing fungi.
Several procedures can be used to control the growth of OA-producing fungi. Chelack et al. (1991a,bl demonstrated that gamma or electron beam irradiation is a highly effective means of destroying spores from a specific OA producing fungi, A. ulutuceus. Leitao et al. (1990) have reported that phosphine was effective at inhibiting both fungal growth and sterigmatocystin production by A. versicolor. Tong and Draughan (19851 studied the effects of several antimicrobial food additives on the growth and production of OA by Aspergillus and Penicillium species of fungi. For foods with pH values of from 5 to 6, such as the cereals or sorghum, the antimicrobial agent of choice was methyl paraben or potassium sorbate. Small concentrations of these compounds completely inhibited growth and production of OA by both genera of fungi. At pH 4.5, as occurs in silage, fungal growth and toxin production was com-pletely inhibited by .02% potassium sorbate, .07% methyl paraben, and .2% sodium propionate. Overall, it may be concluded that OA production in grain can be effectively controlled by storage a t < 15% moisture. Storage at higher moisture levels requires that grain be maintained under anaerobic conditions or that a combination of mold inhibitors and sterilization techniques, possibly coupled with the inoculation of nontoxigenic competitive microflora, be applied. Limited research has been carried out in this area.
Chemical Detoxification of Ochratoxin A and Effect of Ensiling. Many chemicals have been tested for their ability to structurally degrade and(ox-1 inactivate aflatoxins, including numerous acids, bases, aldehydes, bisulfates, oxidizing agents, and various gases, as well as ensiling. Other than ammoniation, many of the techniques proposed to remove mycotoxins are currently perceived as impractical, ineffective, and(or1 potentially unsafe for largescale use (CAST, 1989) . Madsen et a1. (1983) reported that treatment of OA-contaminated barley with 501' 0 NH3 for 96 h a t 7OoC, warming of grain to 105OC in the presence of .5% NaOH, and autoclaving at 132OC for .5 h only slightly improved the nutritional value of barley fed to pigs. Although only 15% of the pretreatment OA was detected in the treated grain, the corresponding decrease in OA concentration in the tissue of pigs fed treated grain was much less. Madsen et al. (1983) concluded that such treatments did not effectively reduce the concentration of OA and were not practical. In contrast, Chekowski et al. (1981 Chekowski et al. ( , 1982 reported that treatment of OA-contaminated grain with ammonia reduced OA concentrations to undetectable levels. Weight gains of chickens fed the contaminated grain were markedly decreased, whereas there was no reduction in weight gains when the chickens were fed the OA-contaminated grain that had been ammoniated. They concluded that ammoniation of grain not only detoxifies several mycotoxins including OA but also inhibits mold growth. Rotter et al. (1990) reported that inoculation of barley with a Lactobacillus species followed by ensiling reduced the apparent concentration of OA by approximately 500/0. This treatment, however, had no effect on the toxicity of OA as assessed by poultry feeding studies. The toxin may have been complexed to the organic matrix or converted into an undetected or unidentified derivative during storage. Apparently the enzymes produced by Lactobacillus inoculant were not able to hydrolyze the amide bond of OA efficiently and thereby reduce its toxicity.
Binding Agents to Reduce Ochratoxin A Availability. Several different approaches have been used to reduce OA absorption, including the use of sodium calcium aluminosilicate, bentonite, charcoal, and cholestyramine. The addition of hydrated sodium calcium aluminosilicate (1%) and bentonite (1 and 10%) to a diet containing OA had no effect on OA concentration in swine blood serum, tissues, and bile. The addition of 1 9 ' 0 activated charcoal to the diet, in contrast, caused a slight decrease in the concentration of OA in swine blood, whereas 10% charcoal decreased the concentration of OA in blood, liver, kidney, spleen, and heart by 50 to 80% (Bauer, personal communication) . It was concluded that the administration of 10% activated charcoal may have therapeutic value as a feed additive but cannot be regarded as practical in prophylaxis. Rotter et al. (1989a) also concluded that supplementation of OA-contaminated diets with activated charcoal was a n impractical method of reducing OA toxicity in chicks that were continuously consuming OA.
Cholestyramine, in contrast to the nonspecific absorbents discussed above, seems to be an effective absorbent of OA in the gastrointestinal tract of nonruminant animals (Madhyastha et al., 1992a) . Cholestyramine is a commercial anion exchange resin that has been shown to effectively sequester bile salts and to reduce hypercholesteremia in humans (Vahouny, 1982) . Madhyastha et al. (1992a) demonstrated that the inclusion of as low as .5% cholestyramine in a rat diet containing 1 mg/kg of OA reduced blood OA concentrations by 50%. In another experiment it was shown that dietary cholestyramine greatly reduced cumulative urinary excretion of OA (26 to 6 pg) and increased cumulative fecal excretion of OA (8 to 38 pg) in rats given a single oral dose of OA. A reduced bioavailability of OA should result in a reduced toxic effect. Further studies are required to determine efficacy of similar, but less expensive, anion exchange adsorbents.
Effects of Phenylalanine and Protein on Ochratoxin A Toxicity. The phenylalanine moiety of OA competitively inhibits a t least two enzymes, phenylalanyl-tRNA synthetase and phenylalanine hydroxylase, resulting in reduced protein synthesis and altered rates of tyrosine production from phenylalanine. The addition of phenylalanine to cell cultures containing OA (Creppy et al., 1983b) or coadministration of phenylalanine with OA Moroi et al., 1985) reduced or prevented the OA-associated inhibition of protein synthesis. Injection of phenylalanine also prevented OA-induced immunosuppression in mice (Haubeck et al., 1981; Creppy et al., 1982) and partially reduced teratogenesis in rats (Mayura et al., 1984) . Phenylalanine supplementation of diets contaminated with OA seemed to provide protection against OA-induced toxicity in chicks but also tended to create a n amino acid imbalance, which A REVIEW OF OCHRATOXICOSIS 3983 reduced BW gain and feed conversion efficiencies (Rotter et al., 1989b; Gibson et al., 1990; . These studies suggest that little or no benefit is obtained by supplementing OA-contaminated diets with phenylalanine. The concentration of protein in the diet of growing chicks was also shown to ameliorate the toxicity of OA Gibson et al., 1989) . The consumption of high-protein diets (26%) by growing chicks over a 3-wk period compared to a diet containing a lower concentration of protein (1 4%) decreased the toxicity produced by 4 mg/kg of OA as indicated by rate of growth, mortality, clinical chemistry measurements, and relative size of digestive and other organs. Protein protected against the negative effects of OA, presumably because of the increased concentration of phenylalanine in the diet. This treatment, however, may not be practical because a large change in the concentration of dietary protein may be costly and produces relatively small benefits.
Role of Microorganisms in Disposition of
Ochratoxin A in Ruminant and Nonruminant Animals and Modifying Effects of Diet. Gastrointestinal microorganisms have a large effect on the disposition of OA because they promote the hydrolysis of OA to its nontoxic alpha form. This is particularly important in ruminants (Sreemannarayana et al., 1988; Xiao et al., 1991a,b) but is also of consequence in nonruminants (Madhyastha et al., 1992b) . In addition, the type of diet also affects the disposition of OA in the rumen Niao et al., 1991a,bl. Ruminal fluid obtained from hayfed animals (pH 7.0) was able to hydrolyze OA to O a in vitro five times faster than ruminal fluid obtained from grain-fed animals (pH 5.5). Disappearance of OA from the rumen and the corresponding formation of Oa was also much faster for hay-fed than for grain-fed sheep; the half-lives were .63 and 2.7 h for OA and .9 and 1.9 h for Ocx, respectively. The bioavailability of OA in sheep fed grain was 4.3 times greater than that in sheep fed hay. Thus, the rumen of the sheep has an important role in the detoxification of OA and the type of diet affects the rate and extent of this process. As a result, the bioavailability of OA, and probably the toxicity to the animal, is decreased. The studies of Madhyastha et al. (1992b) suggest that the intestinal microflora of nonruminant animals also affect the bioavailability of OA. They speculated that factors that influence the microbial population in the cecum and large intestine may therefore affect OA disposition.
Reversal of Toxic Effects of Ochratoxin A by Ascorbic Acid. Haazele (1992) reported that ascorbic acid supplementation (300 mg/kg) of laying hen diets that contained 3.0 mg/kg of OA partially ameliorated OA toxicity, including its negative effect on the production of eggs or egg mass and plasma Ca, Na, and C1. Ochratoxin A in the diet reduced production of egg mass and blood sodium and increased blood Ca by 35, 3, and 32%, respectively, whereas the corresponding changes in the presence of ascorbic acid were only 16, 1, and 6Yo. The results indicate that dietary ascorbic acid provides considerable protection against toxic effects of OA in the laying hen. The mechanism of the effect is not known but it may affect the production of lipid peroxides by OA.
Conclusion
Ochratoxin A is a mycotoxin that causes many adverse effects in domestic livestock and humans. It has been implicated in the fatal human disease Balkan endemic nephropathy, and it is known to cause nephropathy in swine. In addition, it can cause subacute and chronic production losses in domestic livestock and poultry. Ochratoxin A seems to produce its toxic effect by one of three mechanisms: inhibition of phenylalaninemetabolizing enzymes (OA contains a phenylalanine moiety), promotion of lipid peroxidation, or inhibition of mitochondrial ATP production. Other effects seem to be secondary. Ochratoxin A is of concern because there is a high potential for its production in stored foods and feeds under appropriate temperature and moisture conditions, it has been known to occur naturally in grains and food, it has been detected in the blood of swine and humans a t a high frequency in different areas of the world, and it is a potent carcinogen and nephrotoxin. The production of OA in grain, particularly when stored under high-moisture conditions, can be readily controlled. The toxic effect of OA can be reduced by treatment of OAcontaminated grain (perhaps ammoniation and enzymatic hydrolysis of OA to Oa in ruminants and nonruminants), by reducing its absorption from the gastrointestinal tract (cholestyramine), or by feeding diets that will reduce its toxic effects (vitamin C). The presence of OA in meat, poultry, and dairy products may be readily monitored in the future with the availability of rapid immunobased assays that may be used by the livestock producer, the meat packing or poultry processing plant, and regulatory agents. These assays are inexpensive, sensitive, and highly specific (Chu, 1992) . Assays of OA in the blood can provide a measure of OA in other tissues because blood concentrations are highly correlated with tissue levels. On-farm monitoring of the blood of a few pigs, for example, should indicate overall OA status of the herd and, if it is positive, specific diets can be fed for a short time to facilitate the 3984 MARQUARDT clearance of OA from the animal. The use of proper management practices in areas that favor OA production would further reduce problems associated with OA contamination of the feed supply. Currently, information is lacking on the presence of OA in certain environmental niches, on detailed means of controlling the effects of OA, and on available diagnostic procedures for the rapid and inexpensive detection of OA in the food and feed supply. These will become more important when it is more widely realized that OA intakes cause significant but sporadic and widely variable adverse effects in the livestock industry and that OA when transmitted into the human food chain is a health hazard. Export of agricultural products to foreign countries could be affected by regulations in these countries.
Implications
Ochratoxins are a group of mycotoxins that are produced by storage fungi (molds) under highmoisture conditions and optimal temperatures. They have been detected in North America in grains and in the blood of both swine and in humans. They are of concern because they can have acute or chronic effects in animals that result in production losses, are known to be potent carcinogens, and have been implicated in the fatal human kidney disease referred to as Balkan endemic nephropathy. Prevention of occurrence and detoxification before or after feeding seem to be methods by which ochratoxin A in the food and feed supply can be controlled.
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